Stem Holdings Inc. (OTCQB: STMH), A Publicly Traded

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
131
Stem Holdings Inc. (OTCQB: STMH), A Publicly Traded Company, Partner Brands Receive Multiple Awards

Boca Raton, FL, June 26, 2018 (GLOBE NEWSWIRE) -- Stem Holdings is proud to announce that this past weekend two of our partner brands received recognition at the 2018 BudFest King Canna Cup. Held in Eugene, Oregon this event brought together Oregon’s best cannabis companies to compete in 12 categories. TJ’s Gardens received two awards for their no-till living soil flower, and incredibles received two awards for their delicious and popular chocolate bars.

TJ’s CBD took home first place in the Best Cannabidiol (CBD) Flower category. Cannabidiol or CBD is one of the non-psychoactive components found in the cannabis or hemp plant. Additionally, TJ’s Monkey Tape received 2nd Place for Best Hybrid Flower. Incredibles was honored with two 2nd Place finishes at the competition. Their Strawberry Crunch bar was recognized in the Best Tetrahydrocannabinol (THC) Edible category, and their Cookies & Cream bar received an award in the Best Cannabidiol (CBD) Edible category.

“We are very proud to be recognized by the local community for cultivating high-quality flower,” says TJ’s Gardens founder James Orpeza. “We are always striving to improve our growing practices, it means a lot to constantly win awards at different competitions annually. It’s even more special that we share this honor with one of our favorite partners, incredibles.”

TJ’s Gardens has been collaborating with Colorado founded incredibles for the past year introducing their brand to the Oregon market. TJ’s Gardens and incredibles are two of the most awarded cannabis companies in the country, and Stem Holdings is excited that their partnership is being recognized at events and competitions such as BudFest.

“We've been committed to producing the most delicious quality and consistent edibles since 2010. It's why we partnered with TJ's Gardens to deliver no-til organic living soil cannabis infused in our trusted cannabis products. This awards means so much!” says Steven Chang, National Sales Director for incredibles. “We want to thank BudFest, the other award winners, and the entire Oregon cannabis community for a great event."

About Stem Holdings Inc. Stem Holdings has positioned itself as a leader in the U.S. cannabis industry by building state-of-the-art licensed solutions to include: cultivation, processing and retail properties across multiple U.S. markets. As an innovative real estate company, Stem Holdings acquires and improves properties for the cannabis industry. Because traditional institutional lenders have not directly participated in the financing of marijuana-related real estate, there has been a shortage of available improvement capital.  Stem Holdings has set itself apart by building and partnering with a variety of marijuana-based businesses, from edibles to hemp cultivation. The Company has developed an extensive portfolio of award-winning consumer-facing brands, partnering with well known, branded cannabis operators with a proven track record of success, such as TJ’s Gardens, Cannavore, incredibles, Doseology and Green T-Farms. For more information, visit www.stemholdings.com About TJ’s Gardens TJ’s Gardens is Oregon’s premier cannabis cultivation company. Using only no-till living soil growing methods, TJ’s has won 30+ awards at High Times Cannabis Cup events, Dope Cup events, NW Cannabis Classic competitions, and many other notable cannabis competitions located in the Pacific Northwest. The company was also recognized by High Times for producing “The Best Tasting Buds on Earth” (TJ’s Durban Poison strain) two years in a row. For more information, visit www.tjsgardens.com

About MC Brands, LLC. Originally founded in 2010, Medically Correct, LLC (whose IP is licensed by MC Brands LLC) has grown into Colorado’s highest-volume and most nationally awarded cannabis-infused product manufacturing company. The business’s reputation for high-quality extracts and product innovation, and its investment in long-term growth, has solidified incredibles’ position as an industry leader. Passionate about delivering reliable products focused on product safety, extraction purity, ingredient quality, lab testing and compliant packaging. incredibles’ mission is to advocate on behalf of the cannabis industry and help propel it forward. Featuring a full line of THC-infused terpene-rich cannabis products, incredibles, incredible Extracts® and incredible Wellness® continue to lead the industry in innovative chocolates, vape pens, extracts and confections with more product lines in development. For more information, visit iloveincredibles.com

Cautionary Note Regarding Forward-Looking Information

This press release contains statements which constitute "forward-looking information" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Stem Holdings Inc. with respect to future business activities. Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and include information regarding: (i) expectations regarding the size of the U.S. cannabis market (ii) the ability of the Company to successfully achieve its business objectives, (iii) plans for expansion of Stem Holdings Inc., and (iv) expectations for other economic, business, and/or competitive factors.

Investors are cautioned that forward-looking information is not based on historical facts but instead reflect Stem Holdings Inc. management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Stem Holdings believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the combined company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: the potential impact of the announcement of the going public transaction on relationships, including with regulatory bodies, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in the financial markets; and in particular in the ability of the Company to raise debt and equity capital in the amounts and at the costs that it expects; adverse changes in the public perception of cannabis; decreases in the prevailing prices for cannabis and cannabis products in the markets that the Company operates in; adverse changes in applicable laws; or adverse changes in the application or enforcement of current laws, including those related to taxation; the inability to locate and acquire suitable companies, properties and assets necessary to execute on the Company's business plans; and increasing costs of compliance with extensive government regulation. This forward-looking information may be affected by risks and uncertainties in the business of Stem Holdings and market conditions.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Stem Holdings has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Stem Holdings does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.

No securities regulatory authority has in any way passed upon the merits of the proposed transactions described in this news release or has approved or disapproved of the contents of this news release.

For further information, please contact: Investor Relations Contact: Amato and Partners, LLC Investor Relations Counsel 212.460.0360 admin@amatoandparnters.com Media Contact: Mauria Betts Director of Branding and Public Relations (971) 266-1908 mauria@stemholdings.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

FDA Greenlights Kisqali®: A Major Step for Breast Cancer Care

Updated Category News Views 203

Kisqali® Receives FDA Approval for Early Breast Cancer Treatment Novartis has some exciting news for oncology: the US Food and Drug Administration (FDA) has officially approved Kisqali® (ribociclib) as a treatment for patients diagnosed with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early breast cancer...

Continue Reading
Ålandsbanken Abp Launches SEK 350M Additional Tier 1 Notes Series

Updated Category News Views 162

Ålandsbanken Abp Issues SEK 350,000,000 Additional Tier 1 Notes Ålandsbanken Abp, a prominent player in the banking industry, recently made waves in the financial market by issuing Additional Tier 1 floating rate notes amounting to SEK 350,000,000. The issuance marks a significant step in Ålandsbanken's strategic move to strengthen its capital position and enhance its...

Continue Reading
Harbour BioMed's 2025 Achievements and Future Prospects

Updated Category News Views 249

Harbour BioMed Achieves Significant Milestones in Interim Results Harbour BioMed (HKEX: 02142) is a prominent biopharmaceutical company focused on developing innovative antibody therapeutics, particularly in the fields of immunology and oncology. The company shared its impressive interim results for the first half of the year, showcasing remarkable growth and strategic...

Continue Reading
Innovative Investment Fuels Okika Devices' Future Growth Strategy

Updated Category News Views 187

Strategic Investment Boosts Okika Devices Advancement Colorado ONE Fund, which is part of the ONE Funds initiative, has made a major investment in Okika Devices, a company recognized for its innovation in Field Programmable Analog Array (FPAA) technology. This investment aligns with Colorado ONE Fund's mission to support technologies that advance the local innovation...

Continue Reading
Investors Take Note: Legal Options for Shareholders Explored

Updated Category News Views 61

Exploring Legal Options for Investors in Major Companies In recent developments, Halper Sadeh LLC, a reputable law firm focusing on investor rights, is carefully examining three significant companies for potential violations of federal securities laws. This investigation centers around the actions and decisions made by these firms, which may affect shareholders' rights...

Continue Reading